Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-05-11 Sale |
2021-05-13 07:44 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
19,804 | $10.22 | $202,413 | 73,128 (Direct) |
View |
2021-03-16 Sale |
2021-03-17 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
127,244 | $11.22 | $1,427,614 | 20,598 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 4:12 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
13,930 | $10.57 | $147,186 | 111,633 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
19,608 | $10.56 | $207,091 | 161,994 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 4:08 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
12,935 | $10.58 | $136,909 | 25,870 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
9,515 | $10.57 | $100,536 | 206,322 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
6,183 | $10.58 | $65,443 | 169,232 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
6,012 | $10.57 | $63,523 | 205,646 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
7,513 | $10.58 | $79,521 | 142,425 (Direct) |
View |
2021-03-02 Sale |
2021-03-04 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
15,548 | $10.85 | $168,631 | 15,571 (Direct) |
View |
2021-03-03 Sale |
2021-03-04 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
1,400 | $10.88 | $15,231 | 0 (Direct) |
View |
2021-03-02 Sale |
2021-03-04 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
50,000 | $10.82 | $540,890 | 64,064 (Direct) |
View |
2021-03-03 Sale |
2021-03-04 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
606 | $10.86 | $6,583 | 70,058 (Direct) |
View |
2021-03-03 Sale |
2021-03-04 4:01 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
993 | $10.88 | $10,803 | 11,873 (Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:10 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
18,430 | $10.83 | $199,612 | 58,264 (Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
73,127 | $10.91 | $798,023 | 104,758 (Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
75,587 | $10.87 | $821,925 | 45,534 (Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
10,912 | $10.83 | $118,186 | 179,112 (Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
9,795 | $10.85 | $106,285 | 107,834 (Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
7,486 | $10.83 | $81,079 | 121,302 (Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $10.85 | $223,507 | 72,560 (Direct) |
View |
2021-02-16 Sale |
2021-02-17 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
3,926 | $11.12 | $43,669 | 2,974 (Direct) |
View |
2021-02-16 Sale |
2021-02-17 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
2,098 | $11.12 | $23,336 | 103,294 (Direct) |
View |
2021-02-16 Sale |
2021-02-17 4:06 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
2,079 | $11.13 | $23,135 | 39,572 (Direct) |
View |
2021-02-09 Sale |
2021-02-11 4:12 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
65,312 | $12.69 | $829,103 | 53,396 (Direct) |
View |
2021-02-09 Sale |
2021-02-11 4:08 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
20,694 | $12.69 | $262,700 | 94,267 (Direct) |
View |
2021-02-09 Sale |
2021-02-11 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
21,635 | $12.72 | $275,217 | 72,351 (Direct) |
View |
2021-02-09 Sale |
2021-02-11 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
29,496 | $12.69 | $374,437 | 154,042 (Direct) |
View |
2021-02-09 Sale |
2021-02-11 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
17,979 | $12.72 | $228,709 | 82,177 (Direct) |
View |
2021-02-09 Sale |
2021-02-11 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
29,657 | $12.69 | $376,481 | 72,539 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-05-11 Exercise |
2021-05-13 07:44 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
37,884 | $0 | 73,128 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
80,798 | $0 | 111,633 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
13,930 | $0 | 111,633 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
285,171 | $0 | 1,265,156 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
59,701 | $0 | 1,265,156 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
95,057 | $0 | 274,740 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
15,920 | $0 | 274,740 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
109,315 | $0 | 161,994 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
18,905 | $0 | 161,994 (Direct) |
View |
2021-03-04 Option Award |
2021-03-08 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
12,935 | $0 | 25,870 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
12,935 | $0 | 25,870 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
85,551 | $0 | 85,551 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
95,057 | $0 | 206,322 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
18,905 | $0 | 206,322 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
90,304 | $0 | 169,232 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
11,940 | $0 | 169,232 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
99,809 | $0 | 205,646 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
13,930 | $0 | 205,646 (Direct) |
View |
2021-03-05 Option Award |
2021-03-08 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
90,304 | $0 | 142,425 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
15,920 | $0 | 142,425 (Direct) |
View |
2021-03-03 Exercise |
2021-03-04 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
1,166 | $0 | 15,571 (Direct) |
View |
2021-03-03 Exercise |
2021-03-04 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
1,400 | $0 | 0 (Direct) |
View |
2021-03-03 Exercise |
2021-03-04 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
1,400 | $0 | 70,058 (Direct) |
View |
2021-03-03 Exercise |
2021-03-04 4:01 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
2,101 | $0 | 11,873 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
18,430 | $0 | 58,264 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
65,047 | $0 | 996,024 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
20,598 | $0 | 193,717 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
24,934 | $0 | 104,758 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
15,177 | $0 | 45,534 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
18,430 | $0 | 73,720 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
21,682 | $0 | 179,112 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
19,514 | $0 | 107,834 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
17,346 | $0 | 121,302 (Direct) |
View |
2021-02-28 Exercise |
2021-03-02 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $0 | 72,560 (Direct) |
View |
2021-02-14 Exercise |
2021-02-17 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
3,926 | $0 | 2,974 (Direct) |
View |
2021-02-14 Exercise |
2021-02-17 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
5,712 | $0 | 111,324 (Direct) |
View |
2021-02-14 Exercise |
2021-02-17 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
5,355 | $0 | 103,294 (Direct) |
View |
2021-02-14 Exercise |
2021-02-17 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
3,926 | $0 | 39,572 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
90,658 | $0 | 53,396 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
12,538 | $0 | 53,396 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
226,173 | $0 | 762,701 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
26,867 | $0 | 762,701 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
103,223 | $0 | 159,019 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
15,523 | $0 | 159,019 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
67,852 | $0 | 94,267 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
16,120 | $0 | 94,267 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
50,260 | $0 | 72,351 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
11,941 | $0 | 72,351 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
105,736 | $0 | 154,042 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
16,120 | $0 | 154,042 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
65,527 | $0 | 82,177 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
6,567 | $0 | 82,177 (Direct) |
View |
2021-02-09 Option Award |
2021-02-11 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
55,287 | $0 | 72,539 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
13,135 | $0 | 72,539 (Direct) |
View |